tc-db8
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 3, 2023 (NCT05940298)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07275463 | Phase 2 | Oct 1, 2025 | Russian Academy of Medical Sciences, Uppsala University |
| NCT05940298 | Phase 1 | Jul 3, 2023 | Russian Academy of Medical Sciences, Uppsala University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Russian Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 2 | 2023 |
| Uppsala University | Academic/Hospital | 2 | 0 | 2 | 2023 |
2 organizations
Page 1 / 1